News

ERT announced an upgrade to its flagship platform for centralized respiratory clinical trials, MasterScope.

Most clinical trial activity for Phase III trials takes place in the traditional North American and European markets.

In a comparison study of source data review (SDV) methods, this new process demonstrates the value of using well-planned data visualization tools to provide better quality oversight versus remote eCRF review or onsite SDV.

A new SaaS platform for clinical trials, soon available to all pharma companies, aims to automate clinical supply, improve patient compliance and enable better medication adherence.

KMR Group has recently completed and released their 2016 Best Places for Clinical Research report series.

SCORR Marketing, in partnership with Applied Clinical Trials, recently conducted a survey to ascertain from industry professionals what big data comprises as well as its importance, how it is used today in the industry and how it may impact drug development services in the future.

The Council adopts revision encouraging sponsors to implement improved oversight and management of clinical trials.

Survey collects thoughts from industry professionals on the current and future impact of big data in clinical trials.

Assessing practices and inefficiencies with site selection, study start-up, and site activation.

How one large academic trial adopted a coordinating center model-helping drive early-model RBM gains

Q&A looks at the growing use of unstructured data in drug development and the evolving role of the clinical data manager amid the advent of real-world data as a research aid.

In its first published update since 2011, the CDISC Glossary Project Team has updated this resource, which includes hundreds of definitions for key terminology related to clinical research.

Click the title above to open the Applied Clinical Trials December 2016/January 2017 issue in an interactive PDF format.

The FDA’s Dr. John Whyte recently shared his perspectives on patient centricity at eyeforpharma’s Patient Centered Clinical Trials conference. He continues the discussion by exploring the definition of patient centricity and issues that not only the FDA, but also the industry is facing.

Data sharing in biomedical research has recently attracted widespread attention from physicians, scientists and stakeholders alike. DCRIs Dr. Eric Peterson discusses the context, flaws and positives of how this initiative could be implemented and the effects it can have on the industry.

LabConnect has announced the launch of its data integration services which aims to assist sponsors in coordinating high-volume data collection and management from multiple laboratory data sources.

Finding and implementing an appropriate design for early-stage clinical trials is critical to the future success of medicines for central nervous system (CNS) disorders, according to new analysis from the European Medicines Agency (EMA)

The Clinical Data Interchange Standards Consortium (CDISC) is reminding the clinical research community that the FDA Binding Guidance goes into effect in December.

The latest official review of European health strategy has been released at the request of the European Commission in an attempt to address Europe’s healthcare challenges. Peter O’Donnell reports that the clinical trials community is likely to be disappointed at the report’s findings.

The Society for Clinical Research Sites (SCRS) announces that Roche has become a Global Impact Partner (GIP).

Updated employee announcements, business news and recognition in the industry today.

Medidata has launched its new eConnect Partner Program.

TKL Research, a dermatology specialty clinical research organization, has agreed to sell its Clinical Trials Division to QuintilesIMS.

Vendor oversight in clinical trials is a subject not often discussed despite a disconnect in how it is carried out between multiple departments. Celeste Gonzalez of Boston Scientific shares her perspectives on the subject.